Joseph L. Messa Product Liability Law Blog

Personal injury attorneys report that a jury ruled that Pfizer must pay at least $4¿million in damages to a woman who developed breast cancer after taking Prempro.... Read More

... Read More

A new proposed bill, the Safety of Untested and New Devices (SOUND) Act, was introduced by Representative Edward Markey at a press conference last month. The bill would allow the Food and Drug Administration
to require medical device manufacturers seeking approval for new
devices based on older devices that have safety issues to provide
documentation proving that the new product¿¿¿s design has fixed potential
... Read More

Medical malpractice lawyers at Messa & Associates recently discovered the results of a study, reported by the American College of Cardiology, that revealed that St. Jude Medical¿s Riata
wires may have additional defects. According to the study, the wires
have multiple defects that could lead to melted conductors,... Read More

According to reports and company records, Johnson and Johnson received a letter from the Food and Drug Administration asking for additional safety data just weeks before the company decided to stop selling its DePuy ASR hip implant
in 2009. The device, recalled in August 2010, has since been found to
have a high rate of premature failure. The hip implants were expected to
last for at least 15 years, but had... Read More

Gynecare Prolift and other vaginal mesh devices are used to treat incontinence or help women with pelvic organ prolapse, a condition in which weakened muscles fail to support internal organs.... Read More

The Food and Drug Administration has issued a recall of several types of Automated External Defibrillators (AED)
because certain models contain a component that may fail unexpectedly
due to a defect. If the defective component failed during a rescue
attempt, the AED may not deliver defibrillation therapy and could cause
serious health consequences, including death.

AEDs are equipped with a self-test... Read More

... Read More

A class-action suit in Boston will go to mediation after a federal judge ruled that the claims of 53 breast cancer patients exposed to diethylstilbestrol (DES) should not be dismissed.... Read More

Johnson & Johnson's marketing falsely claimed that the drug, Risperdal, did not carry a diabetes risk.... Read More